FeesSafety
Pluang+

Obexelimab shows sustained benefits in IgG4-related disease, reducing steroid toxicity and supporting vaccine response.

Market News
12 Oct 2026, 18:00 WIB
Na
View Source
Bullish
Obexelimab shows sustained benefits in IgG4-related disease, reducing steroid toxicity and supporting vaccine response.

Zenas BioPharma presented new data on obexelimab at the 6th International Symposium on IgG4-Related Disease, highlighting sustained clinical activity in treating IgG4-RD. Phase 3 INDIGO open-label extension results showed a high probability of patients remaining flare-free after 12 months and significantly reduced glucocorticoid toxicity compared to placebo. Additionally, a vaccine sub-study demonstrated effective immune responses during a treatment-free window without disease flares. These findings support obexelimab's potential as a steroid-sparing therapy for long-term management of this chronic autoimmune disease.

Zenas BioPharma's new data presentation on obexelimab in IgG4-related disease provides context for readers following health sector developments. For readers following health sector stocks, here is Pluang's market snapshot as of Oct 12, 2026 17:11 WIB: of 128 priced health-sector US stocks tradable on Pluang, 58 rose and 42 fell today. Notable movers include BNGO (BioNano Genomics Inc) at USD 1.40 with a -2.44% change and a typical hold time of 50 days, ROIV (Roivant Sciences Ltd.) at USD 34.70 with a -2.09% change and a typical hold time of 3 days, and HRTX (Heron Therapeutics Inc) at USD 0.41 with a +2.07% change and a typical hold time of 36 days.

More News

Diversified Energy buys back 370,570 shares at $13.87 average, reducing shares outstanding to 69.75M

Diversified Energy buys back 370,570 shares at $13.87 average, reducing shares outstanding to 69.75M

Diversified Energy PLC repurchased 370,570 of its common shares between November 12 and 17, 2026, at a volume-weighted average price of $13.87 per share. These shares will be cancelled, reducing the total shares outstanding to 69,752,072. This buybac...

Company Fundamentals
Bullish
27 minutes ago
BW Offshore to release Q3 2026 results and host a conference call on November 25

BW Offshore to release Q3 2026 results and host a conference call on November 25

BW Offshore will announce its Q3 2026 financial results on November 25 at 07:30 CET, followed by a conference call and Q&A session hosted by CEO Marco Beenen and CFO Ståle Andreassen at 13:00 CET. Investors and interested parties can join the webcast...

Company Fundamentals
Neutral
57 minutes ago
SPIE to acquire ENPROM, boosting its high-voltage electrical infrastructure expertise in Central Europe.

SPIE to acquire ENPROM, boosting its high-voltage electrical infrastructure expertise in Central Europe.

SPIE, a leading European multi-technical services provider, has signed an agreement to acquire 100% of ENPROM, a Polish group specializing in high-voltage electrical infrastructure engineering and installation. ENPROM employs over 900 people and serv...

Company Fundamentals
Bullish
57 minutes ago
SPIE to acquire ENPROM Group, boosting high-voltage power engineering in Poland and Germany

SPIE to acquire ENPROM Group, boosting high-voltage power engineering in Poland and Germany

SPIE has signed an agreement to acquire 100% of ENPROM Group, a major electrical power construction company based in Poland. This acquisition will enhance SPIE's capabilities in high-voltage power engineering and installation across Poland and German...

Company Fundamentals
Bullish
57 minutes ago
BNL aims for pre-tax RONE above 20% by 2030 through strategic growth and digital transformation.

BNL aims for pre-tax RONE above 20% by 2030 through strategic growth and digital transformation.

BNL, part of BNP Paribas, is accelerating its growth strategy with a focus on high-value client services in Corporate Banking, Private Banking, and Wealth Management. It plans to enhance profitability by investing in digitalization, AI, and employee ...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App